Clinical study
PHASACO-retro
Phage Safety Retrospective Cohort Study
| Status | Status unconfirmed |
|---|---|
| Type | Observational study |
| Countries | France |
| Conditions studied | Bone and Joint Infection; Prosthetic Joint Infection |
| Study years | 2021–2026 (estimated) |
| Entry review | 2026-10-03 |
Participation
Check the study record or contact the study team for current recruitment and eligibility.
Study eligibility
Inclusion Criteria: * patients having had a bone or joint or implant infection treated by phagotherapy and having had an adverse event Exclusion Criteria: \-
Study description
The aim of this study is to determine the imputability of adverse events in patients who have had phage therapy for the treatment of their bone or joint or implant infection, in order to find out whether these adverse effects are related to surgery, antibiotic treatment or bacteriophages.
Study registrations
| ClinicalTrials.gov | NCT04724603 |
|---|
Recorded study locations (1)
Locations listed in the study record; this does not confirm current recruitment or treatment outside the study. A site label may be older than the overall study status.
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Study ID | nct04724603 |
|---|